HDACs are implicated in the pathogenesis of a number of diseases (e.g., cancer, colitis, cardiovascular disease and neurodegeneration), and HDAC inhibitors are considered as potential therapeutic agents43. Here, HDAC9 is linked to cardiovascular disorder.